Start with what happened in people
Tesamorelin Research: what changed in each study?
Tesamorelin raises growth hormone and growth factor 1. You'll see results in people, one rat finding, the harms, and the limits for your case.
Whose health can tesamorelin research speak to?
The drug tesamorelin tells the growth gland to release more hormone; this page explains the body steps, the study results, and the main harms so you can see which findings fit your case.
The soundest proof comes from adults with HIV and lipodystrophy, a medical word meaning fat has moved to unusual places in the body. Tesamorelin reduced fat buried deep in their bellies.
For people outside that group, the proof remains weak.
The human results stay separate from one rat study. Each part names who was studied, what changed, and how long it took, helping you form sharper questions for your doctor.
How does tesamorelin raise growth factor 1?
Tesamorelin fits a matching part on the outside of growth-gland cells. That fit tells the gland to make growth hormone, then send the hormone out in bursts.
Tesamorelin doesn't put ready-made growth hormone in your body. Instead, your own gland releases more of its stored supply.
The liver responds by making insulin-like growth factor 1, a protein that carries growth orders. Working together, growth hormone and growth factor 1 help the body use stored fat, with the clearest study change deep inside the belly.
After two weeks, healthy men's glands released more growth hormone, and growth factor 1 rose [4][6]. Their own glands made the hormone after tesamorelin delivered the first order.
One study used rats, not people. Researchers gave them another drug that fits the same cell part. After heart damage, the rats' heart tissue moved toward its earlier size and shape [10], a change the paper described as repair. A blocking drug stopped that repair. Blood levels of growth hormone and growth factor 1 didn't clearly rise. Rat hearts can't show how your heart would respond.
Tesamorelin's first protein part is also changed, so the body cuts the drug apart more slowly.
What changed most in the tesamorelin studies?
The strongest finding came from a 26-week Phase 3 study of 412 adults with HIV. Scans showed 15.2% less deep belly fat with 2 milligrams of tesamorelin each day. The placebo group received a shot without medicine and gained 5.0% [1]. Triglycerides, which are blood fats, fell 50 milligrams per deciliter. Growth factor 1, the liver-made growth protein, rose 81.0%. A deciliter is one-tenth of a liter.
A 52-week study followed 273 people taking tesamorelin and 137 taking placebo. Their deep belly fat remained 18% lower [2], though fat began returning after treatment ended.
An earlier 12-week Phase 2 study followed 61 adults with HIV. Growth factor 1 rose 48% with 1 milligram each day and 65% with 2 milligrams each day. Chest and belly fat fell, while blood sugar stayed much the same [7].
A 6-month study followed 50 adults taking HIV drugs. Scans showed 42 square centimeters less deep belly fat, not inches lost from the waist. Liver fat fell by 2.9% [3].
A 2026 review combined five trials with comparison groups. Deep belly fat fell by 27.71 square centimeters on average. Its 95% range ran from 17.06 to 38.37 square centimeters of loss. In plain words, the review's math put the true average inside that span, and every point in the span meant a loss. Chest and belly fat fell 1.18 kilograms, and liver fat fell 4.28%. Tissue that wasn't fat rose 1.42 kilograms. That total includes muscle, bone, water, and organs, so the review couldn't call all of it muscle. No serious harm was blamed on tesamorelin [12].
Everyone studied had the fat problem tied to HIV. The results can't tell you that your body would change the same way.
For whom did tesamorelin reduce belly fat?
How large was the deep-belly-fat change with tesamorelin?
Adults who had HIV and lipodystrophy took 2 milligrams of tesamorelin each day. After 26 weeks, deep belly fat was 15.2% lower. People given placebo, a shot without medicine, gained 5.0% [1]. No large study has shown the same loss among people who don't have HIV. The FDA hasn't cleared general fat loss [5].
Where in the belly did tesamorelin change fat?
Scans found less fat packed around the organs [1]. Both BMI and fat just under the skin moved little; BMI uses height and weight to give a rough size measure. The proof covers fat trouble tied to HIV, not every reason for a large belly [5].
How long did the measured fat loss remain?
Researchers checked deep belly fat at 26 weeks. It stayed lower through 52 weeks while people remained on tesamorelin [1][2]. Those are study dates, not a promise about your body.
What have studies shown in people without HIV?
The strongest proof comes from adults with HIV who were taking HIV drugs [1][2]. Similar body steps may occur in others, but no large trial has proved this yet. The FDA hasn't approved such use [5]. A 2026 review said researchers are still testing whether tesamorelin can preserve muscle during weight loss [14].
What happened to liver fat during tesamorelin studies?
Who received tesamorelin for fatty liver not caused by drink?
Only adults with HIV were studied. Their liver fat fell by 2.9% [3]. The FDA hasn't approved tesamorelin for fatty liver [5]. A 2022 review discussed the drug as a possible future treatment when deep belly fat raises the risk of liver scarring [11]. The review didn't show that tesamorelin reduced scars; more study is needed.
Did losing belly fat help the liver too?
Adults with HIV and fatty liver lost 2.9% of their liver fat [3]. Deep belly fat also fell at the same time [3]. Because both changed together, the study couldn't tell whether the drug acted on liver fat directly or the liver improved as belly fat fell. A government review found clear liver harm unlikely. It found no cases blamed on tesamorelin and no new rises in liver blood tests [5].
How often did researchers find lower liver fat?
One 6-month study found liver fat was 2.9% lower [3]. A 2026 review that combined several studies found an average drop of 4.28% [12]. Everyone studied had HIV. The results don't settle what would happen in your liver without HIV.
Which tesamorelin warnings could matter to you?
The FDA label rules out tesamorelin during pregnancy or active cancer. Any past cancer treatment must be complete, with no active cancer left. A serious allergy to tesamorelin or another ingredient also rules it out [5].
The drug raises growth hormone and growth factor 1, the liver-made growth protein [5]. Skin trouble where the shot entered was the most common problem in studies [1]. Growth hormone drugs can also cause swelling by making the body hold fluid.
Among 13 healthy men, neither fasting blood sugar nor insulin's work moving sugar from blood changed clearly [4]. A 12-week study also found no clear change [7]. Changes over 52 weeks were too small to affect care [2]. Blood sugar can still move, so your doctor may test yours if you have added risk.
A 2026 review combined five trials with comparison groups. No serious harm was blamed on tesamorelin in those trials [12]. A government review also found clear liver harm unlikely [5]. Neither finding removes the cancer warning. The concern is that growth factor 1 might help a cancer grow while helping healthy tissue grow [5].
Tesamorelin is banned in tested sport both during and outside contests [13]. That rule doesn't tell you whether the drug is safe treatment.